Evolent Health (EVH) Operating Expenses (2015 - 2026)

Evolent Health's Operating Expenses history runs 12 years deep, the most recent figure standing at $506.8 million for Q1 2026.

• On a quarterly basis, Operating Expenses rose 4.45% year-over-year to $506.8 million in Q1 2026; TTM through Mar 2026 was $2.3 billion, a 4.92% decrease from a year earlier, with the FY2025 full-year figure at $2.3 billion, down 11.9% from the prior year.
• Operating Expenses declined to $506.8 million in Q1 2026 per EVH's latest filing, from $877.0 million in the prior quarter.
• Across five years, Operating Expenses topped out at $877.0 million in Q4 2025 and bottomed at $299.9 million in Q1 2022.
• The 5-year median for Operating Expenses is $490.7 million (2023), against an average of $516.0 million.
• Across the five-year window, Operating Expenses jumped 55.74% in 2023 and slumped 30.32% in 2025, its largest moves.
• Year by year, Operating Expenses stood at $384.3 million in 2022, then soared by 50.24% to $577.4 million in 2023, then gained by 15.19% to $665.1 million in 2024, then soared by 31.84% to $877.0 million in 2025, then sank by 42.2% to $506.8 million in 2026.
• Per Business Quant, the three latest EVH Operating Expenses figures stand at $506.8 million (Q1 2026), $877.0 million (Q4 2025), and $478.6 million (Q3 2025).